Jatenzo 198 MG capsule 120S
Ended Awarded
- Contract number
- SPE2DB26FCGRL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,311
Award facts
- Contract value 100% obligated
- $2,310.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded October 28, 2025, to AmerisourceBergen Drug Corp represents a competitive, firm fixed-price procurement of JATENZO 198 mg capsules (120-unit supply) valued at $2,310.50. The award was made by the Defense Logistics Agency (DLA), the Department of Defense's supply and logistics arm, with an ultimate completion date of October 29, 2025. This is a non-set-aside contract, meaning it was awarded through open competition rather than under a small business or other designated preference program. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters.
This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the pharmaceutical distributor to supply a comprehensive range of medications and medical supplies to support military healthcare systems globally. JATENZO is a testosterone replacement therapy medication, consistent with AmerisourceBergen Drug Corp's portfolio of specialty pharmaceuticals and brand-name drugs delivered to Defense Health Agency and other federal healthcare entities through the DLA's medical supply chain.
Quick answers
Who was awarded contract SPE2DB26FCGRL?
SPE2DB26FCGRL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DB26FCGRL worth?
The government has obligated $2,311 on SPE2DB26FCGRL.
Is contract SPE2DB26FCGRL an order under another contract?
Yes. SPE2DB26FCGRL is a delivery order under SPE2DB24D2013, an indefinite delivery contract.
Was contract SPE2DB26FCGRL competed?
The extent of competition for SPE2DB26FCGRL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award